TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle
Abstract Background TUBA1C is an α-tubulin isoform involved in mitosis, and its dysregulation has been implicated in tumor progression. There is still no clear understanding of its role in bladder urothelial carcinoma (BLCA). Methods This study examined the differential expression of TUBA1C and its...
Main Authors: | Yi Jiang, Chao Zhu, Haoxuan Huang, Gaomin Huang, Bin Fu, Xiaoqing Xi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-11209-2 |
Similar Items
-
Identification of Immune-Related Subtypes and Construction of a Novel Prognostic Model for Bladder Urothelial Cancer
by: Jiange Zhang, et al.
Published: (2022-11-01) -
Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle
by: Mugahed Abdullah Hasan Albahde, et al.
Published: (2020-02-01) -
Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma
by: Tingting Bian, et al.
Published: (2021-03-01) -
Multidimensional pan-cancer analysis of HSPA5 and its validation in the prognostic value of bladder cancer
by: YaXuan Wang, et al.
Published: (2024-03-01) -
RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update
by: Rong-Quan He, et al.
Published: (2018-10-01)